Understand the source comparison
Snap-8 vs Botulinum Toxin vs Argireline: Research Comparison
Snap-8 (acetyl octapeptide-3) SNARE complex competitive inhibition. Reversible binding to syntaxin/VAMP 2–4 hours topical 6–8 hours per application 63% (dynamic) / 27% (static) at 10% twice daily, 28 days Temporary surface effect. No collagen synthesis. Requir
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Snap-8 (acetyl octapeptide-3)
- SNARE complex competitive inhibition. Reversible binding to syntaxin/VAMP
- 2–4 hours topical
- 6–8 hours per application
- 63% (dynamic) / 27% (static) at 10% twice daily, 28 days
- Temporary surface effect. No collagen synthesis. Requires continuous reapplication. Does not address skin quality.
- Botulinum toxin type A (Botox)
- SNAP-25 proteolytic cleavage. Irreversible enzymatic destruction
- 24–72 hours post-injection
- 3–4 months
- 80–95% dynamic wrinkle elimination (published meta-analysis)
- Gold standard for neuromuscular wrinkle reduction. Invasive. High cost. Requires medical administration. Addresses muscle tone only.
- Argireline (acetyl hexapeptide-8)
- SNARE complex inhibition (shorter peptide chain)
- 2–6 hours topical
- 4–6 hours per application
- 30% (dynamic) at 10% twice daily, 30 days
- Less potent than Snap-8. Better tolerability in sensitive skin. Same limitation: no dermal remodelling.